Pasithea Therapeutics Corp. (KTTA) News
Filter KTTA News Items
KTTA News Results
| Date | Symbol | Company | Title | Start | End | Change | POWR Rating | ||
|---|---|---|---|---|---|---|---|---|---|
| Loading, please wait... | |||||||||
KTTA News Highlights
- For KTTA, its 30 day story count is now at 3.
- Over the past 17 days, the trend for KTTA's stories per day has been choppy and unclear. It has oscillated between 1 and 1.
- DEC are the most mentioned tickers in articles about KTTA.
Latest KTTA News From Around the Web
Below are the latest news stories about PASITHEA THERAPEUTICS CORP that investors may wish to consider to help them evaluate KTTA as an investment opportunity.
Pasithea Therapeutics Announces Adjournment of Reconvened Meeting of Stockholders to December 29, 2023SOUTH SAN FRANCISCO, Calif. and MIAMI, Dec. 28, 2023 (GLOBE NEWSWIRE) -- Pasithea Therapeutics Corp. (“Pasithea” or the “Company”) (NASDAQ: KTTA) today announced that its meeting of stockholders, which had been partially adjourned on December 19, 2023, was reconvened on December 28, 2023 (the “Meeting”) and then was further adjourned, without conducting any business, in order to provide stockholders additional time within which to vote on the charter amendment proposals included as Proposals 4, |
Pasithea Therapeutics Announces Results from 2023 Annual Meeting-- Solicitation Continues for Certain Charter Amendment Proposals –SOUTH SAN FRANCISCO, Calif. and MIAMI, Dec. 19, 2023 (GLOBE NEWSWIRE) -- Pasithea Therapeutics Corp. (“Pasithea” or the “Company”) (NASDAQ: KTTA), today announced that it held its annual meeting of stockholders (the “Annual Meeting”) on December 19, 2023. Over 70% of the Company’s shares of common stock were represented at the Annual Meeting. More than 95% of shares voted were cast “for” the election of directors (Proposal 1), an |
PLTR Stock: Palantir Renews UniCredit PartnershipPalantir Technologies stock is slipping on Wednesday even with positive news for PLTR investors in the form of a renewed contract. |
RBLX Stock Alert: Wells Fargo Initiates Roblox Coverage With ‘Overweight’ RatingRoblox stock is rising higher on Wednesday after Wells Fargo initiated coverage of RBLX shares wit a bullish rating and price target. |
Why Is Pasithea Therapeutics (KTTA) Stock Down 12% Today?Pasithea Therapeutics stock is falling on Wednesday after shares of KTTA underwent extreme volatility yesterday on study results. |
Why Is ReShape Lifesciences (RSLS) Stock Up 68% Today?ReShape Lifesciences stock is rising with heavy trading of RSLS shares alongside an update from the FDA concerning its weight loss products. |
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on WednesdayPre-market stock movers are a hot topic on Wednesday and we're starting the day with a breakdown of the biggest ones worth watching! |
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on TuesdayChecking out the biggest pre-market stock movers for Tuesday is the perfect way to get ready for another busy day of trading! |
Why Is Pasithea Therapeutics (KTTA) Stock Up 105% Today?Pasithea Therapeutics stock is climbing higher with heavy trading of KTTA shares alongside results from two preclinical trials. |
Pasithea Therapeutics Announces Positive In Vivo Preclinical Efficacy Data for PAS-004 from NRAS Mutation Cancer Xenograft Models-- Preclinical data continues to demonstrate PAS-004’s potentially superior properties as compared to FDA approved MEK inhibitors -- -- Once daily dose of PAS-004 delivers anti-tumor efficacy in in vivo NRAS mutation cancer models -- SOUTH SAN FRANCISCO, Calif. and MIAMI, Dec. 11, 2023 (GLOBE NEWSWIRE) -- Pasithea Therapeutics Corp. (NASDAQ: KTTA) (“Pasithea” or the “Company”), a biotechnology company focused on the discovery, research, and development of innovative treatments for Central Nervou |